SSA
FEED

Schonfeld Strategic Advisors’s ENVUE MEDICAL INC NEW FEED Stock Holding History

Schonfeld Strategic Advisors’s Portfolio FEED Stock Details FEED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,129
Closed -$32.2K – 2856
2026
Q1 		$32.2K Buy
+1,129
New +$29.3K ﹤0.01% 2016

Other funds holding FEED

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Schonfeld Strategic Advisors's FEED Position: Q2 2026 in Review

Schonfeld Strategic Advisors sold out of ENVUE MEDICAL INC NEW (FEED) in Q2 2026, closing a stake of 1,129 shares — an estimated $32.2K sold.

Schonfeld Strategic Advisors first reported a position in FEED in Q1 2026 and held it in 1 quarter. The position peaked at $32.2K in Q1 2026. 12 funds tracked by Wall St. Rank hold FEED as of Q2 2026.

  • Schonfeld Strategic Advisors reported no remaining ENVUE MEDICAL INC NEW position as of Q2 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 1,129 ENVUE MEDICAL INC NEW shares in Q2 2026, an estimated $32.2K.
  • Schonfeld Strategic Advisors first reported a position in ENVUE MEDICAL INC NEW in Q1 2026 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's ENVUE MEDICAL INC NEW position peaked at $32.2K in Q1 2026.
  • 12 funds tracked by Wall St. Rank held ENVUE MEDICAL INC NEW as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.